Meglumine antimoniate adverse reactions
| Meglumine Antimoniate |
|---|
| GLUCANTIM® WHO Prescribing Information |
| Description |
| Indications and Usage |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Dosage and Administration |
| How Supplied |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Adverse effects
Adverse effects
Electrocardiographic changes are dose-dependent and usually reversible; typically, T-wave inversion and prolongation of the Q-T interval precede serious dysrhythmias.
Hepatic and renal function may be impaired.
Headache, malaise, dyspnoea, skin rashes, facial oedema and abdominal pain are also occasionally associated with treatment.[1]
References
References
Adapted from the FDA Package Insert.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH